ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.018,81
-0,34%
US Dollar vs BRL
5,1959
0,01%
Bitcoin
56.896,71
-6,11%
Brent Oil
83,60
-2,67%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Catalyst Pharmaceuticals Inc (CPRX)

  7. Catalyst Pharmaceuticals Inc (CPRX) Notícias

CPRX Catalyst Pharmaceuticals Inc

15,30
0,25 (1,66%)
Última atualização: 13:36:40
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Catalyst Pharmaceuticals Inc CPRX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,25 1,66% 15,30 13:36:40
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
15,13 14,97 15,395 15,05
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202409:00GLOBECatalyst Pharmaceuticals to Participate at the BofA..
22/04/202409:00GLOBECatalyst Pharmaceuticals to Report First Quarter 2024..
28/03/202409:03GLOBECatalyst Pharmaceuticals Announces Support for the Inaugural..
27/03/202409:03GLOBECatalyst Pharmaceuticals to Participate in the 2024 Cantor..
13/03/202408:55GLOBECatalyst Pharmaceuticals Announces AGAMREE® Now Commercially..
05/03/202410:03GLOBECatalyst Pharmaceuticals to Participate at the Barclays 26th..
28/02/202420:03GLOBECatalyst Pharmaceuticals Reports Strong Fourth Quarter and..
27/02/202410:03GLOBECatalyst Pharmaceuticals to Present at MDA Clinical &..
21/02/202411:00GLOBECatalyst Pharmaceuticals Announces Publication of Santhera..
14/02/202410:03GLOBECatalyst Pharmaceuticals to Report Fourth Quarter and..
09/01/202418:05GLOBECatalyst Pharmaceuticals, Inc. Announces Closing of Public..
05/01/202410:02GLOBECatalyst Pharmaceuticals, Inc. Announces Pricing of Public..
04/01/202418:49GLOBECatalyst Pharmaceuticals, Inc. Announces Proposed Public..
18/12/202308:30GLOBECatalyst Pharmaceuticals Announces FIRDAPSE® New Drug..
05/12/202310:03GLOBECatalyst Pharmaceuticals Receives Prestigious Ranking on..
04/12/202310:03GLOBECatalyst Pharmaceuticals Announces Appointment of Michael W...
16/11/202310:05GLOBECatalyst Pharmaceuticals To Participate in Piper Sandler..
08/11/202318:11GLOBECatalyst Pharmaceuticals Reports Strong Third Quarter 2023..
02/11/202311:37GLOBECatalyst Pharmaceuticals Receives Two New U.S. Patent..
30/10/202309:03GLOBECatalyst Pharmaceuticals Partners with Sofie's Journey to..
26/10/202316:19GLOBECatalyst Pharmaceuticals Reports FDA Approval of AGAMREE®..
23/10/202309:03GLOBECatalyst Pharmaceuticals to Report Third Quarter 2023..
19/10/202309:03GLOBECatalyst Pharmaceuticals Appoints Richard J. Daly as Chief..
16/10/202309:03GLOBEPatrick J. McEnany, Chairman and CEO of Catalyst..
13/10/202309:03GLOBECatalyst Pharmaceuticals Announces FDA Acceptance of the..
18/09/202309:03GLOBECatalyst Pharmaceuticals to Participate at the 2023 Cantor..
16/08/202311:56GLOBECatalyst Pharmaceuticals Announces Abstract on Lambert Eaton..
14/08/202309:05GLOBECatalyst Pharmaceuticals Announces Multiple Abstracts on..
09/08/202317:17GLOBECatalyst Pharmaceuticals Reports Strong Second Quarter 2023..
25/07/202309:03GLOBEPatrick J. McEnany Announces Intention to Retire as CEO of..
24/07/202309:03GLOBECatalyst Pharmaceuticals to Report Second Quarter 2023..
19/07/202307:00GLOBECatalyst Pharmaceuticals Acquires Exclusive North American..
20/06/202307:00GLOBECatalyst Pharmaceuticals to License North American Rights to..
01/06/202309:03GLOBECatalyst Pharmaceuticals Reports Positive Momentum in Second..
30/05/202309:03GLOBECatalyst Pharmaceuticals Appoints Tamar Thompson to its..
10/05/202317:27GLOBECatalyst Pharmaceuticals Reports Record First Quarter 2023..
09/05/202309:03GLOBECatalyst Pharmaceuticals Advances sNDA Submission Plans To..

Seu Histórico Recente

NASDAQ
CPRX
Catalyst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados